Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

NEW YORK and LEAMINGTON, Ontario, July 12, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its fourth quarter and full fiscal year ended May 31, 2023 on July 26, 2023.

Tilray Brands, Inc. to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on July 26, 2023

Aurora Cannabis

Canopy Growth

The Canadian cannabis sector has undergone a massive transition in recent years, bringing the country to the forefront of the global cannabis market. As we enter 2023, the landscape of Canadian cannabis stocks and the industry continues to grow at an unparalleled rate, presenting investors and enthusiasts with many opportunities and challenges.

Emerging Trends in Canadian Cannabis Stocks: What Investors Need to Know in 2023

Green Thumb Industries Inc.

SNDL Inc.

Trulieve Cannabis Corp.

Cronos Group

The US cannabis industry is facing challenges including a potential recession, over-regulation, high taxes, and a thriving black market, leading to widespread losses among cannabis companies. Despite these challenges, the industry is still growing, with sales expected to reach between $58 billion and $70 billion by 2030, and cash flow and capex trends moving in the right direction.

The State Of Cannabis Now And Where It Goes Next

Tilray's markets will need to normalize for its stock to consistently post gains. It'll also need to become a lot more efficient at its core marijuana operations.

Is Tilray Brands Stock a Buy Now?

Pot shops and cannabis brands are generating less revenue due to rising competition. Even amid falling pot prices, the illegal market remains a big problem for the cannabis industry.

4 Concerning Stats About Some of Canada's Top Cannabis Markets

IM Cannabis Corp

The Canadian cannabis market and top marijuana stocks have developed incredibly since its legalization in 2018. According to Statista, legal recreational cannabis sales in Canada will reach CAD 4.5 billion in 2022 alone. This number will climb as more stores open nationwide, and more products hit the market.

Investing in Canadian Cannabis Stocks: Unlocking Opportunities in 2023

SweetWater Gummies, a New Hazy Double India Pale Ales Satisfy Craving for Highly Drinkable, High-Strength Craft Beer SweetWater Gummies, a New Hazy Double India Pale Ales Satisfy Craving for Highly Drinkable, High-Strength Craft Beer

SweetWater Brewing Launches Gummies Beer A New Juicy Revolution

GameStop

SoFi Technologies

The meme stock craze of 2021 has largely faded. Yet, retail investors continue to look for stocks in which they can execute a short squeeze.

3 Meme Stocks to Sell Before They Do Your Portfolio In

One of their peers is moving its stock listing onto the top Canadian exchange. This indicates there might be more investor support for the beleaguered pot industry than previously assumed.

Why Tilray and Aurora Cannabis Stocks Surged Higher Today

Do you intend to invest in the top marijuana stocks for the long term? Given the market volatility associated with the best cannabis stocks to watch, it may be difficult to locate long-term investments that provide a general sense of stability. The cannabis market could more than double in the next five years. In the United States, the cannabis industry will also grow. Congress is currently working on SAFE Banking, which could lead to a new surge in marijuana stocks. Investors can profit from the market's momentum by capitalizing on the sector's revival.

Cannabis ETFs: A Strategic Approach to Long-Term Investing in the Rapidly Expanding Marijuana Sector

For its Third Annual Collectors Art Series, Breckenridge Distillery Partners with Local Colorado Artist to Create Label for its New, Limited Release, PX Naranja Cask Finish Whiskey For its Third Annual Collectors Art Series, Breckenridge Distillery Partners with Local Colorado Artist to Create Label for its New, Limited Release, PX Naranja Cask Finish Whiskey

Breckenridge Distillery Launches New Limited Release Collectors Art Series With Artist Sandra Fettingis

Wall Street's high hopes for Tilray stock are not entirely unfounded. But problems in the cannabis industry make major growth unlikely this year.

Tilray Stock Could Climb 114%, per Wall Street. Is It Actually Possible?

HEXO Corp

Canada continues to face an oversupply of cannabis that has pushed down prices even as the cost of capital has increased, which will result in more consolidation ahead, one executive told MarketWatch on Friday.

As Tilray buys Hexo, former exec sees more consolidation ahead in Canadian cannabis

Curaleaf Holdings, Inc.

Innovative Industrial Properties

Although 23 states and the District of Columbia have legalized the recreational sale of marijuana, banking and taxation rules impeded the growth that many thought would have skyrocketed by now.

Can The SAFE Act Light Up High Hopes For Cannabis Industry?

Creates Canada's Largest Cannabis Company by Revenue and Increases Tilray's #1 Leading Cannabis Share by 44% with ~13% Pro Forma Market Share

Tilray Brands Completes Accretive Acquisition of HEXO Corp. Leading the Next Evolution of Canadian Cannabis

The US is seeing a surge in cannabis legalization, with 39 states allowing medical use and 21 states permitting recreational use. Despite this, the cannabis industry has been grappling with economic and industry challenges, such as oversupply and inflation, which have created a tough environment for the industry in 2022 and beyond.

From Hero to Zero: 3 Cannabis Stocks to Avoid Like the Plague

New York's Leading Craft Brewer Introduces New Summer Beers and Expands Brew Barn Bar Locations Across Popular Venues New York's Leading Craft Brewer Introduces New Summer Beers and Expands Brew Barn Bar Locations Across Popular Venues

Montauk Brewing Company Celebrates 11-Year Anniversary and Announces 2023 Summer Season Lineup

Hexo Corporation (NYSE:HEXO), the producer of high-quality cannabis products which has agreed to a takeover by Tilray Brands Inc (NASDAQ:TLRY), has reported a decline in net revenues and an adjusted EBITDA loss for the third quarter of its 2023 fiscal year. The company also noted that at a special meeting on Wednesday, June 14, 2023, Hexo shareholders approved the Tilray takeover arrangement agreement.

Tilray takeover target Hexo posts decline in third-quarter financials

Cannabidiol products are gaining acceptance, and the Kansas City Royals announced a partnership with a company that makes them. But the partnership involves a hemp company, not a marijuana business.

CBD Products Are More Common, but That Doesn't Mean Marijuana Legalization Is Inevitable

Tilray Introduces New Easy-Drinking Light Beer Brand, Good Supply, in the U.S. Tilray Introduces New Easy-Drinking Light Beer Brand, Good Supply, in the U.S.

Tilray Brands Expands Beer Portfolio and Launches Good Supply Light Beer

Village Farms International

Since its legalization in 2018, the Canadian cannabis industry has grown extraordinarily, and Canadian marijuana stocks have experienced extreme volatility. Legal recreational cannabis sales in Canada hit CAD 4.5 billion in 2022 alone, according to Statista reports. This figure could rise as more stores open nationwide, and more products enter the market.

Canadian Cannabis Stocks with Growth Potential in June 2023

Blink Charging

Marathon Digital Holdings

Some investors made big money in the meme stock rally of 2021. Multi-bagger returns in few days or weeks is like a dream coming true.

3 Meme Stocks That Could Skyrocket in the Next 12 Months

Clever Leaves Holdings Inc

When looking for the best marijuana stocks to buy it is important to note that investing in the cannabis sector carries risks. The cannabis industry is relatively new and evolving. Currently, this comes with regulatory challenges and varying legal frameworks across jurisdictions. Additionally, the market is volatile, and individual companies may face operational or financial difficulties. Thorough research, careful analysis, and diversification are essential when considering marijuana as an investment. Volatility is a big part of the sector which can make or break certain traders.

3 Marijuana Stocks To Buy For Cannabis Investment Options?

Tilray just issued a fair amount of convertible debt. On a positive note, it also refinanced some existing debt.

Tilray's Stock Just Crashed 21%. Here's Why It's a Better Buy Than Before.

As the cannabis industry continues to grow, interest in marijuana penny stocks has surged. These stocks present an appealing investment opportunity for those eager to capitalize on the expanding legal marijuana market without a substantial financial outlay.

News for Tilray Brands Stock (TLRY)